8FW-67843-64419
2 vaccinations
2 coded responses
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 537 / WI
- Registered
- 2022-07-05
- Relationship
- Child or adolescent in my care
- Guardian
- UHA-13817-13364
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-05
Registered in v-safe
-
2022-07-05
Dose 1 — Moderna
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-09
-
2022-07-10
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · SleepinessUnder 3 check-in
- 2022-07-11
- 2022-07-12
- 2022-07-21
- 2022-07-26
-
2022-08-04
Dose 2 — Moderna
- 2022-08-04
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-18
-
2022-08-25
Survey response — day 21, dose 2, under 3MedDRA: Fatigue, Rash — Feeling: FairFree text: Fatigiue, rashMedDRA releases: 2024-11 · check-in free text available
- 2022-09-01
- 2022-09-08
- 2022-11-03
-
2023-02-02
Survey response — 6 months, dose 2, under 3MedDRA: Conjunctivitis, Cough, Nasal congestion, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-02
Report sent to call center — 6 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-05 | Moderna | No |
| 2 | 2022-08-04 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-02 | Successful 2023-02-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Fatigiue, rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release